Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: A cohort study. (2023)
Attributed to:
Epidemiological contribution to primary and secondary prevention of diabetes and obesity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/dom.14872
PubMed Identifier: 36099041
Publication URI: http://europepmc.org/abstract/MED/36099041
Type: Journal Article/Review
Volume: 25
Parent Publication: Diabetes, obesity & metabolism
Issue: 2
ISSN: 1462-8902